CEO Stéphane Bancel on Friday stated that the company is lowering its annual revenue forecast due to the timing of shipments ...

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

The Cambridge-based vaccine maker, which became a household name during the pandemic, is cutting its global workforce to ...

It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

Moderna CEO Stéphane Bancel and Sen. Bernie Sanders sparred over how much the company owes the federal government for its investment in developing the company’s Covid-19 vaccine.

So far, Bancel is sitting near the top of the highest-paid biopharma CEOs in 2023—with the caveat that many U.S.-based companies have yet to reveal their executive compensation numbers for the year.

M oderna CEO Stéphane Bancel is starting to reap gargantuan gains from the stock he first got when he started with the company a decade ago, although nearly all of this chunk of his fortune ...

After another year of transformational revenue from the company's COVID-19 vaccine, Moderna has rewarded CEO Stéphane Bancel with a pay package of $19.4 million, according to a proxy statement ...

In the face of senators’ criticism, Moderna CEO Stéphane Bancel did not agree to lower the commercial cost of the company’s Covid-19 vaccine in a hearing Wednesday on the vaccine’s price.